Quantcast
Last updated on April 24, 2014 at 13:57 EDT

Fuse Science, Inc. Expands Product Distribution to South America and Europe

December 18, 2012

MIAMI LAKES, Fla., Dec. 18, 2012 /PRNewswire/ — Fuse Science, Inc. (OTCQB: DROP, www.fusescience.com), an innovative consumer products company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, is pleased to announce today that it has commenced overseas sales of its EnerJel(TM) brand product through non-exclusive international distribution partnerships in both South America and Europe. Initial efforts have now begun in Venezuela and Holland, with additional countries expected to follow through several other distribution partners who are anticipated to join the Fuse team. Beginning in January, the Company will commence shipment of its new DROP technology brand products, as well as the EnerJel(TM) Brand into this international distribution channel.

“Each month we take calculated steps to grow our business in each of our three growth engines,” said Brian Tuffin, CEO of Fuse Science. “This is another significant milestone that expands the reach of our technology to global consumers who are already expressing the desire to understand what it means to be ‘Powered By Fuse(TM)!’ We will continue to push these high-margin efforts as part of our business model to increase shareholder value.”

The first of our South American distributors can be found at www.fusevzla.com. If you still don’t know what it means to be “Powered By Fuse(TM)”, then it’s time. Go to www.poweredbyfuse.com and learn more about the products and the company.

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated “DROP” form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

    For more information:          To schedule an interview:
    Fuse Science, Inc.             Gus DeQuesada
    Investor Relations             Michelsen Advertising
    Direct: (305) 503-3873, Ext. 2 C-305-733-1410 / 786-488-7138
    Email: ir@fusescience.com      prnews@michelsenadvertising.com

Safe Harbor Statement
Certain statements and information included in this release may constitute “forward-looking statements” as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management’s projections, estimates and expectations is contained in the Company’s SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Fuse Science, Inc.


Source: PR Newswire